“Predictive value of TGF-β1 and SMAD-7 expression at diagnosis for treatment response in low-risk myelodysplastic syndrome” (2025) Biomolecules and Biomedicine, 25(5), pp. 1175–1183. doi:10.17305/bb.2025.11564.